Special Issue: Antibiotic treatment for COVID-19 complications could fuel resistant bacteria

Antibiotics do not directly affect SARS-CoV-2, the respiratory virus responsible for COVID-19, but viral respiratory infections often lead to bacterial pneumonia. Physicians can struggle to tell which pathogen is causing a person’s lung problems, he surge of COVID-19 patients could ultimately lead to a surge in antibiotic-resistant bacteria—a concern serious enough that the U.S. Department of Defense (DOD) is assembling a group of at least 10 medical centers to study “secondary” bacterial and fungal infections in these patients and the antibiotics being used to prevent them.

Submit manuscript at : https://www.imedpub.com/submissions/environmental-toxicology-studies-journal.html or as an email attachment to [email protected]

30+ Million Readerbase
Recommended Conferences
Flyer image